These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34783405)

  • 1. Hematological changes associated with COVID-19 infection.
    Al-Saadi EAKD; Abdulnabi MA
    J Clin Lab Anal; 2022 Jan; 36(1):e24064. PubMed ID: 34783405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haematological manifestations of COVID-19: From cytopenia to coagulopathy.
    Agbuduwe C; Basu S
    Eur J Haematol; 2020 Nov; 105(5):540-546. PubMed ID: 32663356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early hematological indicators of severe COVID-19 disease in hospitalized patients: Data from a South Asian population.
    Sharif F; Khan S; Junaid A; Jahangir S; Saeed M; Ijaz M; Ahmad IN; Kamran S
    Int J Lab Hematol; 2021 Oct; 43(5):1237-1242. PubMed ID: 33837662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematological Abnormalities in COVID-19: A Narrative Review.
    Rahman A; Niloofa R; Jayarajah U; De Mel S; Abeysuriya V; Seneviratne SL
    Am J Trop Med Hyg; 2021 Feb; 104(4):1188-1201. PubMed ID: 33606667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which hematological markers have predictive value as early indicators of severe COVID-19 cases in the emergency department?
    Şan İ; Gemcioğlu E; Davutoğlu M; Çatalbaş R; Karabuğa B; Kaptan E; Erden A; Küçükşahin O; Ateş İ; Karaahmetoğlu S; Hasanoğlu İ; İnan O; Ünal BN; Erdemir E; Kahraman FA; Güner R
    Turk J Med Sci; 2021 Dec; 51(6):2810-2821. PubMed ID: 33726485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity and coagulation and fibrinolytic processes may reduce the risk of severe illness in pregnant women with coronavirus disease 2019.
    Zhong Y; Cao Y; Zhong X; Peng Z; Jiang S; Tang T; Chen H; Li X; Xia Y; Cheng Y; Zhao X
    Am J Obstet Gynecol; 2021 Apr; 224(4):393.e1-393.e25. PubMed ID: 33098813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematological findings and complications of COVID-19.
    Terpos E; Ntanasis-Stathopoulos I; Elalamy I; Kastritis E; Sergentanis TN; Politou M; Psaltopoulou T; Gerotziafas G; Dimopoulos MA
    Am J Hematol; 2020 Jul; 95(7):834-847. PubMed ID: 32282949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological and Hematological Response in COVID-19.
    Słomka A; Martucci G; Raffa GM; Malvindi PG; Żekanowska E; Lorusso R; Suwalski P; Kowalewski M
    Adv Exp Med Biol; 2021; 1352():73-86. PubMed ID: 35132595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of hematological, coagulation and inflammatory biomarker's role in predicting the severity of disease in patients with COVID-19, admitted in designated COVID-19 hospital of central India.
    Lokwani DP; Yadav BS; Bharti S; Gupta V; Toppo N
    Indian J Pathol Microbiol; 2021; 64(4):735-740. PubMed ID: 34673594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection.
    Lin S; Mao W; Zou Q; Lu S; Zheng S
    J Clin Lab Anal; 2021 Jan; 35(1):e23604. PubMed ID: 33184946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy.
    Popadic V; Klasnja S; Milic N; Rajovic N; Aleksic A; Milenkovic M; Crnokrak B; Balint B; Todorovic-Balint M; Mrda D; Zdravkovic D; Toskovic B; Brankovic M; Markovic O; Bjekic-Macut J; Djuran P; Memon L; Brajkovic M; Todorovic Z; Hadzi-Djokic J; Jovanovic I; Nikolic D; Zdravkovic M
    Oxid Med Cell Longev; 2021; 2021():6648199. PubMed ID: 33968298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic Assessment of Hematological Parameters as Predictive Biomarkers for Disease Severity and Prognosis in COVID-19 Patients: A Longitudinal Study.
    Patange AP; Desai JV; Pujari B; Marwah A; Dey A
    Cureus; 2024 Jul; 16(7):e63593. PubMed ID: 39087175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?
    Tahir Huyut M; Huyut Z; İlkbahar F; Mertoğlu C
    Int Immunopharmacol; 2022 Apr; 105():108542. PubMed ID: 35063753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The looming storm: Blood and cytokines in COVID-19.
    Kaur S; Bansal R; Kollimuttathuillam S; Gowda AM; Singh B; Mehta D; Maroules M
    Blood Rev; 2021 Mar; 46():100743. PubMed ID: 32829962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.
    Janssen NAF; Grondman I; de Nooijer AH; Boahen CK; Koeken VACM; Matzaraki V; Kumar V; He X; Kox M; Koenen HJPM; Smeets RL; Joosten I; Brüggemann RJM; Kouijzer IJE; van der Hoeven HG; Schouten JA; Frenzel T; Reijers MHE; Hoefsloot W; Dofferhoff ASM; van Apeldoorn MJ; Blaauw MJT; Veerman K; Maas C; Schoneveld AH; Hoefer IE; Derde LPG; van Deuren M; van der Meer JWM; van Crevel R; Giamarellos-Bourboulis EJ; Joosten LAB; van den Heuvel MM; Hoogerwerf J; de Mast Q; Pickkers P; Netea MG; van de Veerdonk FL
    J Infect Dis; 2021 Apr; 223(8):1322-1333. PubMed ID: 33524124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients.
    Benotmane I; Perrin P; Vargas GG; Bassand X; Keller N; Lavaux T; Ohana M; Bedo D; Baldacini C; Sagnard M; Bozman DF; Chiesa MD; Cognard N; Olagne J; Delagreverie H; Marx D; Heibel F; Braun L; Moulin B; Fafi-Kremer S; Caillard S
    Transplantation; 2021 Jan; 105(1):158-169. PubMed ID: 33009284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of CBC and WBC Morphology in the Diagnosis and Clinical Course of COVID-19 Infection.
    Pozdnyakova O; Connell NT; Battinelli EM; Connors JM; Fell G; Kim AS
    Am J Clin Pathol; 2021 Feb; 155(3):364-375. PubMed ID: 33269374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematological manifestations of COVID-19.
    Mina A; van Besien K; Platanias LC
    Leuk Lymphoma; 2020 Dec; 61(12):2790-2798. PubMed ID: 32643489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.